REDWOOD CITY, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that management will participate in four upcoming investor conferences.
The Stifel 2024 Healthcare Conference (New York, NY)
- Monday, November 18, 2024, at 2:25 pm ET, management will participate in a fireside chat
- Tuesday, November 19, 2024, at 9:30 am GMT, management will participate in a fireside chat
- Tuesday, November 19, 2024, management will host 1x1 investor meetings
- Thursday, November 21, 2024, at 12:00 pm CT, management will participate in a fireside chat
About Codexis
Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.
For More Information
Investor Contact
Carrie McKim
(336) 608-9706
Media Contact
Lauren Musto
(650) 421-8205
